International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2 , Pages 282-289 , 1 June 2002

Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses

Poster presentation at the Annual ASTRO Meeting, San Francisco, CA, November 2001.

  • Lucille N Lee, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering at Mercy Medical Center, Rockville Center, NY; USA
    • ,
  • Carlton Barnswell, M.D.

      Affiliations

    • Department of Urology, Mercy Medical Center, Rockville Center, NY; USA
    • ,
  • Taryn Torre, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering at Mercy Medical Center, Rockville Center, NY; USA
    • ,
  • Paul Fearn, B.A.

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NYUSA
    • ,
  • Michael Kattan, Ph.D.

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NYUSA
    • ,
  • Louis Potters, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Louis Potters, M.D., Department of Radiation Oncology, MSKCC at Mercy Medical Center, 1000 North Village Avenue, Rockville Center, NY 11570USA. Tel: (516) 256-3600; Fax: (516) 256-1644
    • Department of Radiation Oncology, Memorial Sloan-Kettering at Mercy Medical Center, Rockville Center, NY; USA

Received 30 October 2001 ,Revised 31 December 2001 ,Accepted 10 January 2002.

References 

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15–36
  2. Alexander GA, Brawley OW. Prostate cancer treatment outcome in blacks and whites (A summary of the literature). Semin Urol Oncol. 1998;16:232–234
  3. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology. 1995;45:93–101
  4. Connell PP, Ignacio L, Haraf D, et al.  Equivalent racial outcome after conformal radiotherapy for prostate cancer (A single departmental experience). J Clin Oncol. 2001;19:54–61
  5. Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 2000;56:87–91
  6. Eastham JA, Kattan MW. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol. 2000;163:143–145
  7. Young CD, Lewis P, Weinberg V, Lee TT, Coleman CW, Roach M. The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy. Semin Urol Oncol. 2000;18:121–126
  8. Sohayda CJ, Kupelian PA, Altsman KA, Klein EA. Race as an independent predictor of outcome after treatment for localized prostate cancer. J Urol. 1999;162:1331–1336
  9. Hart KB, Wood DP, Tekyi-Mensah S, Porter AT, Pontes JE, Forman JD. The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy. Int J Radiat Oncol Biol Phys. 1999;45:1235–1238
  10. Zagars GK, Pollack A, Pettaway CA. Prostate cancer in African-American men (Outcome following radiation therapy with or without adjuvant androgen ablation). Int J Radiat Oncol Biol Phys. 1998;42:517–523
  11. Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221–230
  12. Nath R, Meigooni AS, Melillo A. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants. Int J Radiat Oncol Biol Phys. 1992;22:1131–1138
  13. Cha CM, Potters L, Ashley R, et al.  Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;45:391–395
  14. American Society for Therapeutic Radiology and Oncology Consensus Panel . Consensus statement (Guidelines for PSA following radiation therapy). Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  15. Kattan MW, Fearn PA, Leibel S, Potters L. The definition of biochemical failure in patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1469–1474
  16. Mettlin CJ, Murphy GP, McGinnis LS, Menck HR  American College of Surgeons Commission on Cancer and the American Cancer Society . The National Cancer Data Base report on prostate cancer. Cancer. 1995;76:1104–1112
  17. Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995;46:71–77
  18. Fowler JE, Bigler SA, Bowman G, Kilambi NK. Race and cause specific survival with prostate cancer (Influence of clinical stage, Gleason score, age and treatment). J Urol. 2000;163:137–142
  19. Robbins AS, Whittemore AS, Van Den Eeden SK. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 1998;90:986–990
  20. Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care (Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system). Urology. 1995;46:825–830
  21. Asbell SO, Vijayakumar S. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate. 1997;31:42–46
  22. Vijayakumar S, Winter K, Sause W, et al.  Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study (Results of RTOG 94-12). Int J Radiat Oncol Biol Phys. 1998;40:17–25
  23. Moul JW, Sesterhenn IA, Connelly RR, et al.  Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 1995;274:1277–1281
  24. Mettlin CJ, Murphy GP, Cunningham MP, Menck HR. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer. 1997;80:1261–1266
  25. Schapira MM, McAuliffe TL, Nattinger AB. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care. 1995;33:1079–1088
  26. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer. 1992;70:2152–2158

PII: S0360-3016(02)02747-5

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 2 , Pages 282-289 , 1 June 2002

Article Tools

* Image Usage & Resolution